Eagle Pharmaceuticals
EGRX
#11116
Rank
S$4.24 M
Marketcap
S$0.32
Share price
0.00%
Change (1 day)
-68.37%
Change (1 year)

Earnings for Eagle Pharmaceuticals (EGRX)

Earnings in 2023 (TTM): S$47.6 Million

According to Eagle Pharmaceuticals 's latest financial reports the company's current earnings are S$0.25 Billion. In 2022 the company made an earning of S$84.98 Million, an increase over its 2021 earnings that were of -S$3.76 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Eagle Pharmaceuticals from 2013 to 2023

Annual earnings

Year Earnings Change
2023 (TTM) S$47.6 M-43.98%
2022 S$84.98 M-2361.45%
2021 -S$3.76 Million-111.53%
2020 S$32.57 M2.31%
2019 S$31.84 M-32.89%
2018 S$47.44 M-50.35%
2017 S$95.56 M38.63%
2016 S$68.93 M1966.43%
2015 S$3.33 M-111.46%
2014 -S$29.12 Million282.82%
2013 -S$7.61 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
S$24.15 B 52,400.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
S$16.30 B 35,355.28%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Eli Lilly
LLY
S$44.85 B 97,404.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
S$14.25 B 30,893.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$14.61 B 31,678.79%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
S$9.22 B 19,963.57%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
S$1.57 B 3,332.51%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel